Pneumothorax represents a common clinical problem. An overview of relevant and updated information on epidemiology, pathophysiology, and management of spontaneous (primary and secondary), catamenial, and traumatic (iatrogenic and noniatrogenic) pneumothorax is given.

Pneumothorax is defined as the presence of air in the pleural space. Although intrapleural pressures are negative throughout most of the respiratory cycle [1], air does not enter into the pleural space because the sum of all the partial pressures of gases in the capillary blood averages only 93.9 kPa (706 mm Hg). Hence, net movement of gases from the capillary blood into the pleural space would require pleural pressures lower than –54 mm Hg (i.e., lower than –36 cm H2O), which hardly ever occur in normal circumstances [2]. Hence, if air is present in the pleural space, one of three events must have occurred: (1) communication between alveolar spaces and pleura, (2) direct or indirect communication between the atmosphere and the pleural space, or (3) presence of gas-producing organisms in the pleural space. From a clinical standpoint, pneumothorax is classified as spontaneous (no obvious precipitating factor present) and nonspontaneous (table 1) [2, 3]. Primary spontaneous pneumothorax (PSP) is defined as the spontaneously occurring presence of air in the pleural space in patients without clinically apparent underlying lung disease.

Table 1

Clinical classification of pneumothorax

Clinical classification of pneumothorax
Clinical classification of pneumothorax

PSP has an incidence of 7.4–18 cases (age-adjusted incidence)/100,000 population per year in males, and 1.2–6 cases/100,000 population per year in females [4, 5]. PSP typically occurs in tall, thin subjects. Other risk factors are male gender and smoking. PSP typically occurs at rest [6]. Precipitating factors may be atmospheric pressure changes (which may account for the often observed clustering of PSP) [7] and exposure to loud music [8]. Almost all patients with PSP report a sudden ipsilateral chest pain, which usually resolves spontaneously within 24 h [2]. Dyspnea may be present but is usually mild. Physical examination can be normal in small pneumothoraces. In larger pneumothoraces, breath sounds and tactile fremitus are typically decreased or absent, and percussion is hyperresonant. Rapidly evolving hypotension, tachypnea and tachycardia, and cyanosis should raise the suspicion of tension pneumothorax, which is, however, extremely rare in PSP.

Diagnosis can be confirmed in the majority of cases with an upright posteroanterior chest radiograph, which also makes it possible to estimate the pneumothorax size with good accuracy [9]. In small pneumothoraces, computer tomography may be necessary to diagnose the presence of pleural air. Expiratory chest radiographs are useless [10]. It is important to realize that a contralateral shift of the trachea and mediastinum is a completely normal phenomenon in spontaneous pneumothorax and not at all suggestive of tension pneumothorax; this observation should therefore in no way influence treatment strategies [1]. In a minority of patients, some pleural fluid is present. Rarely, PSP may be associated with a spontaneous hemothorax.

Pathogenesis

The exact pathogenesis of PSP is unknown. The key issue is the spontaneous occurrence of a communication between the alveolar spaces and the pleura. Most authors believe that spontaneous rupture of a subpleural bleb, or of a bulla, is the cause of PSP [10] although alternative explanations are available [11, 12, 13]. Although the majority of PSP patients, including children [14], present blebs or bullae (usually at the apices of the lungs) (fig. 1) [15, 16, 17, 18], it is unclear how often these lesions are actually the site of air leakage [19, 20, 21]. Only a small number of blebs are ruptured at the time of thoracoscopy or surgery, whereas in the remaining cases other lesions are present, often referred to as ‘pleural porosity’ [19, 20, 21]: areas of disrupted mesothelial cells at the visceral pleura, replaced by an inflammatory elastofibrotic layer with increased porosity, allowing air leakage into the pleural space. The latter phenomenon may explain the high recurrence rates of up to 20% of bullectomy alone (without associated pleurodesis) as therapy [22, 23, 24, 25]. The development of blebs, bullae and areas of pleural porosity may be linked to a variety of factors, including distal airway inflammation [21, 22, 23, 24, 25, 26], hereditary predisposition [27], anatomical abnormalities of the bronchial tree [28], ectomorphic physiognomy with more negative intrapleural pressures [29] and apical ischemia [30] at the apices [31], low body mass index and caloric restriction [15, 32], and abnormal connective tissue [33, 34]. The role of increased plasma aluminium concentrations in the pathogenesis of PSP remains unresolved [35, 36].

Fig. 1

Large bulla at the apex of the left lung in a 12-year-old boy with recurrent PSP.

Fig. 1

Large bulla at the apex of the left lung in a 12-year-old boy with recurrent PSP.

Close modal

These lesions may therefore predispose to PSP when combined with (largely unknown) precipitating factors; blebs and bullae indeed also occur in up to 15% of normal subjects [15, 16, 17]. New techniques, such as fluorescein-enhanced autofluorescence thoracoscopy [37](fig. 2) or infrared thoracoscopy [38], may shed more light on this issue, and may be helpful in the detection of the culprit areas during thoracoscopy or surgery. It should be clear, however, that every therapeutic intervention with the purpose of preventing recurrences of PSP should include a pleurodesis technique with or without an intervention at the level of the lung parenchyma [39].

Fig. 2

Air leak identified by fluorescein-enhanced autofluorescence thoracoscopy in a 27-year-old man with recurrent PSP. The air leak was situated at the base of a highly vascularized, severe malformation of the apex of the lung.

Fig. 2

Air leak identified by fluorescein-enhanced autofluorescence thoracoscopy in a 27-year-old man with recurrent PSP. The air leak was situated at the base of a highly vascularized, severe malformation of the apex of the lung.

Close modal

Management

A multitude of therapeutic options are available for treatment of PSP, varying from conservative (observation, oxygen treatment, simple manual aspiration, small catheter drainage) over intermediate (chest tube drainage, medical thoracoscopic talc poudrage or pleural abrasion) to invasive [video-assisted thoracoscopic surgery (VATS) with bleb- or bullectomy, pleural abrasion or partial pleurectomy, or axillary thoracotomy] measures [40]. This and the paucity of large, prospective, randomized clinical trials, as well as the different medical specialists taking care of PSP (pulmonologists, surgeons, radiologists, emergency physicians), probably explain why the present national and international expert opinion-based guidelines [41, 42, 43] are only poorly followed [44, 45, 46, 47]. An algorithmic approach can be proposed (fig. 3).

Fig. 3

An algorithmic approach to the treatment of PSP. * After informed consent or in certain patient groups (aircraft personnel, divers). ** Staple bleb/bullectomy, electrocoagulation, ligation. CTD = Chest tube drainage; PTX = pneumothorax; ELCs = emphysema-like changes.

Fig. 3

An algorithmic approach to the treatment of PSP. * After informed consent or in certain patient groups (aircraft personnel, divers). ** Staple bleb/bullectomy, electrocoagulation, ligation. CTD = Chest tube drainage; PTX = pneumothorax; ELCs = emphysema-like changes.

Close modal

A patient presenting with a first episode of a small (i.e., only partial, usually apical) dehiscence of the lung should not be treated, but can safely be discharged and followed on an outpatient basis.

In case of complete dehiscence of the lung and/or in case of pneumothorax symptoms air evacuation treatment is warranted. There is now sufficient evidence coming from eight papers [48, 49, 50, 51, 52, 53, 54, 55] and three meta-analyses and reviews [56, 57, 58] that simple manual aspiration should be the first-line treatment approach in these PSP patients (table 2). Success rates vary between 50 and 80% of cases, averaging two thirds of cases. Complications are absent, pain and discomfort are minimized, recurrence rates are similar to those seen after typical chest tube drainage, outpatient treatment with immediate discharge is possible in over half the cases, and length of stay, when necessary, is significantly shortened. Alternatively, because repeat aspiration or insertion of a catheter is necessary in one third of patients, some authors propose immediate placement of a small catheter attached to a Heimlich valve followed by immediate discharge [59, 60].

Table 2

Simple manual aspiration as first-line treatment of PSP: immediate success rates

Simple manual aspiration as first-line treatment of PSP: immediate success rates
Simple manual aspiration as first-line treatment of PSP: immediate success rates

There is also good consensus and clinical evidence that PSP recurrence prevention should only be proposed after a first recurrence [39, 40] based on the observation that there is a recurrence in about one third of patients [18], but this may increase to 62% after a first recurrence, and to 83% after a third [61]. Exceptions may be patients at professional risk (aviation personnel, divers), when preferred by anxious patients [39], or when a prolonged air leak (>4 days) [42] is present. Of note, intrapleural insertion of a catheter or tube has only a minimal (if any) effect on recurrence prevention (34–36% observed recurrence rates after chest tube drainage only) [40, 62]. The optimal procedure for recurrence prevention remains controversial because of the paucity of prospective, randomized, large, head-to-head comparative studies.

Intermediate recurrence prevention success rates can be achieved by administration of a sclerosing agent through a chest tube (e.g., talc slurry, tetracycline, minocycline, or doxycycline) [40]. This approach is therefore acceptable only in those patients who are unfit for or refuse thoracoscopy or more invasive surgery.

The choice between ‘medical’ thoracoscopy, ‘surgical’ thoracoscopy (VATS) or open surgery [usually via anterolateral thoracotomy as access method to the pleural cavity depends upon the professional background of the operator (pulmonologist or surgeon), and local availabilities, preferences, beliefs and habits]. Open surgical approaches are slightly superior [63] or equally effective as ‘closed’ thoracoscopic methods [64], but carry a higher morbidity [65]. Therefore, unless there are specific clinical indications for more invasive surgery, it would seem reasonable for thoracoscopy to become the recommended approach [66]. Also, within the surgical community, there is a trend towards less invasive VATS approaches, such as uniportal VATS [67], needle thoracoscopy [68] or even awake VATS procedures [69], which narrows the spectrum between surgical and medical thoracoscopy to almost nil. More important than the technique of access to the pleural space is the procedure which is performed within this space. Bleb and bulla treatment by means of stapled resection, clipping, ligation, looping, laser or electrocautery ablation is still the surgical dogma. When performed without associated pleurodesis, recurrence rates are unacceptably high (up to 20%) [22, 23, 24, 25]. It is therefore questionable, unless a bleb or bulla is clearly leaking (thus ‘flat’) during thoracoscopy, whether a parenchymal procedure is absolutely necessary [39, 40]. Adequate pleurodesis should be the cornerstone of thoracoscopic recurrence prevention. All pleurodesis techniques are based on the successful induction of some form of pleural inflammation [40, 70]. This can be achieved my mechanical abrasion, partial resection, or thoracoscopic instillation of an abrasive agent, usually talc. There is undisputable evidence that the use of size-calibrated talc is absolutely safe, in short- as well as long-term follow-up studies [71, 72, 73, 74]: it does not cause cancer, pulmonary fibrosis, impaired pulmonary function or impaired subsequent thoracic surgery, and it is by far the cheapest agent. Thoracoscopic recurrence prevention techniques, be they ‘medical’ or ‘surgical’, usually show recurrence rates between 0 and 10%. As mentioned earlier, open surgical interventions might even be more successful in experienced hands.

Finally, these therapeutic recommendations are equally valid in children [75, 76] and in pregnancy [77, 78].

A multitude of respiratory disorders have been described as a cause of spontaneous pneumothorax. The most frequent underlying disorders are COPD with emphysema, cystic fibrosis, tuberculosis, lung cancer, HIV-associated Pneumocystis carinii pneumonia, followed by more rare but ‘typical’ disorders such as lymphangioleiomyomatosis and histiocytosis X (table 3). Because lung function in these patients is already compromised, secondary spontaneous pneumothorax (SSP) often presents as a potentially life-threatening disease, requiring immediate action, in contrast with PSP which is more of a nuisance than a dangerous condition. The general incidence is almost similar to that of PSP. Depending upon the underlying disease, the peak incidence of SSP can occur later in life, e.g. at 60–65 years of age in the emphysema population [2].

Table 3

Frequent and/or typical causes of SPP

Frequent and/or typical causes of SPP
Frequent and/or typical causes of SPP

In SSP, dyspnea is the most prominent clinical feature; chest pain, cyanosis, hypoxemia, and hypercapnia, sometimes resulting in acute respiratory failure, can also be present. Diagnosis is confirmed on a posteroanterior chest radiograph; in bullous emphysema, the differential diagnosis with a giant bulla can be difficult, necessitating CT confirmation [79]. As in PSP, air may enter the pleural space through various mechanisms: direct alveolar rupture (as in emphysema or necrotic pneumonia) via the lung interstitium, or backward via the bronchovascular bundle and mediastinal pleura (pneumomediastinum). Recurrence rates usually are higher as compared to those for PSP, ranging up to 80% of cases as is observed in cystic fibrosis [80].

Management

SSP requires immediate air evacuation followed by recurrence prevention at the first episode. All patients with SSP should be hospitalized [40]. Awaiting recurrence prevention treatment, air evacuation can be achieved by simple manual aspiration in young (<50 years old) patients with small pneumothoraces [41], but most authors and guidelines recommend immediate insertion of a chest tube. Small bore chest tubes and even pigtail catheters [81] are usually sufficient; large-bore chest tubes are recommended when large air leaks are suspected or when mechanical positive pressure ventilation is required [42]. Recurrence prevention using a thoracoscopic approach (medical or thoracoscopic) is recommended; in case a visible air leak is present (e.g., a ruptured emphysematous bulla), air leak closure using electrocautery or stapling is indicated. In any case, a pleurodesis procedure such as talc poudrage, pleural abrasion or partial pleurectomy should be performed [3, 82]. In patients in whom lung transplantation is a possible future option (e.g., cystic fibrosis, some cases of COPD), the transplant team should be consulted on whether to perform pleurodesis or not. For most transplant teams, previous pleurodesis does not represent a contraindication for later transplantation.

Catamenial pneumothorax occurs typically within 24–72 h after onset of menstruation. It is often recurrent and may be more common than previously thought [2, 3]. In most cases, catamenial pneumothorax is related to pelvic or thoracic endometriosis [83, 84]. Recurrence prevention treatment is indicated after a first episode of catamenial pneumothorax, because recurrences are frequent. Hormonal suppression treatment is often added.

Pneumothorax ranks second to rib fracture as the most common sign of chest trauma, occurring in up to 50% of chest trauma victims [85]. In half of these cases, pneumothorax may be occult; in chest trauma patients requiring mechanical ventilation, CT of the chest should therefore always be performed [3, 85]. Most surgeons and emergency physicians will place a chest tube in occult and nonoccult traumatic pneumothoraces. However, studies suggest that carefully selected patients may be treated conservatively ultimately requiring chest tube placement only in about 10% of cases [86]. If positive pressure ventilation is anticipated, placement of a chest tube is mandatory. In these cases and in case of an associated hemothorax (20% of patients), placement of a large-bore chest tube (28–36 french) is advocated.

Iatrogenic pneumothorax occurs most often following transthoracic needle biopsy (24%), subclavian vein catheterization (22%), thoracentesis (20%), transbronchial lung biopsy (10%), pleural biopsy (8%) and positive pressure ventilation (7%) [3]. Diagnosis of iatrogenic pneumothorax is often delayed, which should make physicians vigilant. Small and asymptomatic iatrogenic pneumothoraces often do not need any treatment, and resolve spontaneously. In larger or symptomatic pneumothoraces, simple manual aspiration or placement of a small catheter or chest tube attached to a Heimlich valve usually is successful [87]. Larger tubes may be necessary in emphysematous patients or when mechanical ventilation is indicated.

1.
Jantz MA, Anthony VB: Pathophysiology of the pleura. Respiration 2008;75:121&ndash;133.
2.
Noppen M, Schramel F: Pneumothorax. Eur Respir Mon 2002;22:279&ndash;296.
3.
Baumann MH, Noppen M: Pneumothorax. Respirology 2004;9:157&ndash;164.
4.
Bense L, Eklund G, Wilman LG: Smoking and the increased risk of contracting spontaneous pneumothorax. Chest 1987;92:1009&ndash;1012.
5.
Melton LJ, Hepper NGG, Offord KP: Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis 1979;120:1379&ndash;1382.
6.
Bense L, Wilman LG, Hedenstierna G: Onset of symptoms in spontaneous pneumothorax: correlations to physical activity. Eur J Respir Dis 1987;71:181&ndash;186.
7.
Alifano M, Forti Parri SN, Bonfanti B, Arab WA, Passini A, Boaron M, Roche N: Atmospheric pressure influences the risk of pneumothorax: beware of the storm! Chest 2007;131:1877&ndash;1882.
8.
Noppen M, Verbanck S, Harvey J, Van Herreweghe R, Meysman M, Vincken W, Paiva M: Music: a new cause of primary spontaneous pneumothorax. Thorax 2004;59:722&ndash;724.
9.
Noppen M, Alexander P, Driesen P, Slabbynck H, Verstraeten A: Quantification of the size of primary spontaneous pneumothorax: accuracy of the light index. Respiration 2001;68:396&ndash;399.
10.
Bradley M, Willams C, Walshaw MJ: The value of routine expiratory films in the diagnosis of pneumothorax. Arch Emerg Med 1991;8:115&ndash;116.
11.
Light RW: Management of spontaneous pneumothorax. Am Rev Respir Dis 1993;148:245&ndash;248.
12.
Sahn SA, Heffner JE: Spontaneous pneumothorax. N Engl J Med 2000;342:868&ndash;874.
13.
Noppen M: Con: blebs are not the cause of primary spontaneous pneumothorax. J Bronchol 2002;9:319&ndash;325.
14.
Guimaraes CV, Donnely LF, Warner BW: CT findings for blebs and bullae in children with spontaneous pneumothorax and comparison with findings in normal age-matched controls. Pediatr Radiol 2007;37:879&ndash;884.
15.
Amjadi K, Alvarez GG, Vanderhelst E, Velkeniers B, Lam M, Noppen M: The prevalence of blebs and bullae among young healthy adults: a thoracoscopic evaluation. Chest 2007;132:1140&ndash;1145.
16.
Bense L, Lewander R, Eklund G, Hedenstierna G, Wiland G: Non-smoking, non-alpha 1 antitrypsin deficiency-induced emphysema in nonsmokers with healed spontaneous pneumothorax, identified by computed tomography of the lungs. Chest 1993;103:433&ndash;438.
17.
Lesur O, Delorme N, Fromaget JM, Bernadac P, Polu JM: Computed tomography in the etiologic assessment of idiopathic spontaneous pneumothorax. Chest 1990;98:341&ndash;347.
18.
Schramel F, Postmus PE, Vanderschueren RG: Current aspects of spontaneous pneumothorax. Eur Respir J 1997;10:1372&ndash;1379.
19.
Randomsky JBH, Hartel W: Pleuraporosit&auml;t beim idiopathischen Spontanpneumothorax. Pneumologie 1989;43:250&ndash;253.
20.
Masshof W, Hofer W: Zur Pathologie des sogenannten idiopathischen Spontanpneumothorax. Dtsch Med Wschr 1973;98:801&ndash;805.
21.
Ohata M, Suzuki H: Pathogenesis of spontaneous pneumothorax. With special reference to the ultrastructure of emphysematous bullae. Chest 1980;77:771&ndash;776.
22.
Hatz RA, Kaps MF, Meimerakis G, Loehe F, Muller C, Furst H: Long-term results after video-assisted thoracoscopic surgery for first-time and recurrent spontaneous pneumothorax. Ann Thorac Surg 2000;70:253&ndash;257.
23.
Korner H, Andersen KS, Stangeland L, Ellingsen I, Engedal H: Surgical treatment of spontaneous pneumothorax by wedge resection without pleurodesis or pleurectomy. Eur J Cardiothorac Surg 1996;10:656&ndash;659.
24.
Loubani M, Lynch V: Video-assisted thoracoscopic bullectomy and acromycin pleurodesis: an effective treatment for spontaneous pneumothorax. Respir Med 2000;94:888&ndash;890.
25.
Horio H, Nomori H, Kobayashi R, Naruke T, Suemasu K: Impact of additional pleurodesis in video-assisted thoracoscopic bullectomy for primary spontaneous pneumothorax. Surg Endosc 2002;16:630&ndash;634.
26.
Schramel F, Meyer CJ, Postmus PE: Inflammation as a cause of spontaneous pneumothorax and emphysema-like changes: results of bronchoalveolar lavage. Eur Respir J 1995;8:397s.
27.
Morrison PJ, Lowry RC, Nevin NC: Familial primary spontaneous pneumothorax consistent with true autosomal dominant inheritance. Thorax 1998;53:151&ndash;152.
28.
Bense L, Eklund G, Wiman LG: Bilateral bronchial anomaly. A pathogenetic factor in spontaneous pneumothorax. Am Rev Respir Dis 1992;146:513&ndash;516.
29.
Fujino S, Inoue S, Tezuka N, Hanaoka J, Sawai S, Ichinose M, Kontani K: Physical development of surgically treated patients with primary spontaneous pneumothorax. Chest 1999;116:899&ndash;902.
30.
Withers JN, Fishback ME, Kiehl PV, Hannon JL: Spontaneous pneumothorax. Suggested etiology and comparison of treatment methods. Am J Surg 1964;108:772&ndash;776.
31.
Kawajami Y, Irie T, Kawashima K: Stature, lung height, and spontaneous pneumothorax. Respiration 1982;43:35&ndash;40.
32.
Coxson HO, Chan IHT, Mayo JR, Hlynsky J, Nakano Y, Birmingham CL: Early emphysema in patients with anorexia nervosa. Am J Respir Crit Care Med 2004;170:748&ndash;752.
33.
Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez E, Sakai LY, Dietz HC: Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003;33:407&ndash;411.
34.
Loeys BL, Matthys DM, De Paepe AM: Genetic fibrillinopathies: new insights in molecular diagnosis and clinical management. Acta Clin Belg 2003;58:3&ndash;11.
35.
Han S, Sakinci U, Kose SK, Yazhan R: The relationship between aluminum and spontaneous pneumothorax; treatment, prognosis, follow up? Interact Cardiovasc Thorac Surg 2004;3:79&ndash;82.
36.
Leo F, Venissac N, Drici MD, Mouroux J: Aluminium and spontaneous pneumothorax. A suggestive but unconfirmed hypothesis. Interact Cardiovasc Thorac Surg 2005;4:21&ndash;22.
37.
Noppen M, Dekeukeleire T, Hanon S, Stratakos G, Amjadi K, Madsen P, Meysman M, D&rsquo;Haese J, Vincken W: Fluorescein enhanced autofluorescence thoracoscopy in primary spontaneous pneumothorax and normal subjects. Am J Respir Crit Care Med 2006;174:26&ndash;30.
38.
Gotoh M, Yamamoto Y, Igai H, Chang S, Huang C, Yokomisse H: Clinical application of infrared thoracoscopy to detect bullous or emphysematous lesions of the lung. J Thorac Cardiovasc Surg 2007;134:1498&ndash;1501.
39.
Noppen M, Baumann MH: Pathogenesis and treatment of primary spontaneous pneumothorax: an overview. Respiration 2003;70:431&ndash;438.
40.
Tschopp JM, Rami-Porta R, Noppen M, Astoul P: Management of spontaneous pneumothorax: state of the art. Eur Respir J 2006;28:637&ndash;650.
41.
Henry M, Arnold T, Harvey J: BTS guidelines for the management of spontaneous pneumothorax. Thorax 2003;58(suppl 2):ii39&ndash;ii52.
42.
Baumann MH, Strange C, Heffner JE, Light R, Kirby TJ, Klein J, Luketich JD, Panacek EA, Sahn S: Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest 2001;119:590&ndash;602.
43.
De Leyn P, Lismonde M, Ninane V, Noppen M, Slabbynck H, Van Meerhaeghe A, Van Schil P, Vermassen F: Guidelines of the Belgian Society of Pneumology. Guidelines on the management of spontaneous pneumothorax. Acta Chir Belg 2005;105:265&ndash;267.
44.
Jutley RS, Mason R, Cockburn JS: Discrepancies in the detection and management of spontaneous pneumothorax: eight years after publication of guidelines. Scott Med J 2001;46:111&ndash;113.
45.
Mendis D, El-Shanawany T, Mathur A, Redington AE: Management of spontaneous pneumothorax: are BTS guidelines being followed? Postgrad Med J 2002;78:80&ndash;84.
46.
Medford AR, Pepperell JC: Management of spontaneous pneumothorax compared to BTS 2003 guidelines: a district general hospital audit. Prim Care Respir J 2007;16:291&ndash;298.
47.
Kelly AM, Clooney M, Spontaneous Pneumothorax Australia Study Group: Deviation from published guidelines in the management of primary spontaneous pneumothorax in Australia. Intern Med J 2008;38:64&ndash;67.
48.
British Thoracic Society Research Committee: Comparison of simple aspiration with intercostal drainage in the management of spontaneous pneumothorax. Thorax 1993;48:430&ndash;431.
49.
Andrivet P, Djedaini K, Teboul JL, Brochard L, Dreyfuss D: Spontaneous pneumothorax: comparison of thoracic drainage versus immediate or delayed needle aspiration. Chest 1995;108:335&ndash;340.
50.
Noppen M, Alexander P, Driesen P, Slabbynck H, Verstraeten A: Manual aspiration versus chest tube drainage in first episodes of primary spontaneous pneumothorax: a multicenter, prospective, randomized pilot study. Am J Respir Crit Care Med 2002;165:1240&ndash;1244.
51.
Faruqi S, Gupta D, Aggarwal AN, Jindal SK: Role of simple needle aspiration in the management of pneumothorax. Indian J Chest Dis Allied Sci 2004;46:183&ndash;190.
52.
Chan SS, Rainer TH: Primary spontaneous pneumothorax: one-year recurrence after simple aspiration. Eur J Emerg Med 2006;13:88&ndash;89.
53.
Camuset J, Laganier J, Brugi&egrave;re D, Dauriat G, Jebrok G, Thabut G, Fournier M, Mal H: Needle aspiration as first-line management of primary spontaneous pneumothorax. Presse Med 2006;35:765&ndash;768.
54.
Ayed AK, Chandrasekaran C, Sukumar M: Aspiration versus tube drainage in primary spontaneous pneumothorax: a randomized study. Eur Respir J 2006;27:477&ndash;482.
55.
Masood I, Ahmad Z, Pandey DK, Singh SK: Role of simple needle aspiration in the management of spontaneous pneumothorax. J Assoc Physicians India 2007;55:628&ndash;629.
56.
Zehtabchi S, Rios CL: Management of emergency department patients with primary spontaneous pneumothorax: needle aspiration or tube thoracostomy? Ann Emerg Med 2008;51:91&ndash;100.
57.
Wakai A, O&rsquo;Sullivan RG, McCabe G: Simple aspirations versus intercostal tube drainage for primary spontaneous pneumothorax in adults. Cochrane Database Syst Rev 2007;CD004479.
58.
Chan SS: The role of simple aspiration in the management of primary spontaneous pneumothorax. J Emerg Med 2008;34:131&ndash;138.
59.
Marquette CH, Marx A, Leroy S, Vaniet F, Ramon P, Caussade S, Smaiti M, Bonfils C: Simplified stepwise management of primary spontaneous pneumothorax: a pilot study. Eur Respir J 2006;27:470&ndash;476.
60.
Choi SH, Lee SW, Hong YS, Kim SJ, Moon JD, Moon SW: Can spontaneous pneumothorax patients be treated by ambulatory care management? Eur J Cardiothorac Surg 2007;81:491&ndash;495.
61.
Gobbel W: Spontaneous pneumothorax. J Thorac Cardiovasc Surg 1963;46:331&ndash;345.
62.
Almind M, Lange P, Viskum K: Spontaneous pneumothorax: comparison of simple drainage, talc pleurodesis, and tetracycline pleurodesis. Thorax 1989;44:627&ndash;630.
63.
Barker A, Maratos EC, Edmonds L, Lim E: Systematic literature review shows fourfold increase in recurrence rate when similar pleurodesis procedures are performed with a video-assisted approach compared to open approach. Lancet 2007;370:329&ndash;335.
64.
Vohra HA, Adamson L, Weeden DF: Does video-assisted thoracoscopic pleurectomy result in better outcomes than open pleurectomy for primary spontaneous pneumothorax? Interact Cardiovasc Thorac Surg 2008, E-pub ahead of print.
65.
Baldwyck B, Hendricks J, Lauwers P, Van Schil P: Quality of life evolution after surgery for primary and secondary spontaneous pneumothorax: a prospective study comparing different surgical techniques. Interact Cardiovasc Thorac Surg 2008;7:45&ndash;49.
66.
Treasure T: Minimally invasive surgery for pneumothorax: the evidence, changing practice and current opinion. J R Soc Med 2007;100:419&ndash;422.
67.
Salati M, Brunelli A, Xium&egrave; F, Refai M, Sciarra V, Socetti A, Sabbatini A: Uniportal VATS for primary spontaneous pneumothorax: clinical and economical analysis in comparison to the traditional approach. Interact Cardiovasc Thorac Surg 2008;7:63&ndash;66.
68.
Chang YT, Chov SH, Kao EL, Chueng HY, Li HP, Lee JY, Huang MF: Video-assisted extrathoracic bleb excision: an ultra-minithoracotomy for primary spontaneous pneumothorax. Minim Invasive Ther Allied Technol 2007;16:323&ndash;327.
69.
Pompeo E, Tacconi F, Mineo D, Mineo TC: The role of awake video-assisted thoracoscopic surgery in spontaneous pneumothorax. J Thorac Cardiovasc Surg 2007;133:786&ndash;790.
70.
Leo F, V&eacute;nissac N, Pop D, Rosenthal-Allieri A, Mouroux J: Can intrapleural CRP predict VATS pleurodesis failure? Thorac Cardiovasc Surg 2006;54:493&ndash;497.
71.
Noppen M: Who&rsquo;s still afraid of talc? Eur Respir J 2007;29:619&ndash;621.
72.
Hunt I, Barber B, Southon R, Treasure T: Is talc pleurodesis safe for young patients following primary spontaneous pneumothorax? Interact Cardiovasc Thorac Surg 2007;6:117&ndash;120.
73.
Gyorik S, Erni S, Studler U, Hodek-Wuerz R, Tamm R, Chhajed P: Long-term follow up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax. Eur Respir J 2007;29:757&ndash;760.
74.
Cardillo G, Carleo F, Carbone L, Di Martino M, Salvadori L, Ricca A, Petrella L, Martelli H: Long-term lung function following videothoracoscopic talc poudrage for recurrent primary spontaneous pneumothorax. Eur J Cardiothorac Surg 2007;31:802&ndash;805.
75.
O&rsquo;Lone E, Elphick HE, Robinson PJ: Spontaneous pneumothorax in children: when is invasive treatment indicated? Pediatr Pulmonol 2008;43:41&ndash;46.
76.
Tsao K, St Peter SD, Sharp SW, Nair A, Andrews WS, Sharp RJ, Snijder CL, Ostlie DJ, Holcomb GW: Current application of thoracoscopy in children. J Laparoendosc Adv Surg Tech A 2008;18:131&ndash;135.
77.
Lal A, Anderson G, Cowen M, Lindow S, Arnold AG: Pneumothorax and pregnancy. Chest 2007;132:1044&ndash;1048.
78.
Wong MK, Leung WC, Wang JK, Lao TT, Ip MS, Lam WK, Ho JC: Recurrent pneumothorax in pregnancy: what should we do after placing an intercostals drain? Hong Kong Med J 2006;12:375&ndash;380.
79.
Bourgouin P, Cousineau G, Lemire P, H&eacute;bert G: Computed tomography used to exclude pneumothorax in bullous lung disease. J Can Assoc Radiol 1985;36:341&ndash;342.
80.
Edenborough FB, Hussain I, Stableforth DE: Use of a Heimlich flutter valve for pneumothorax in cystic fibrosis. Thorax 1994;49:1178&ndash;1179.
81.
Tsai WK, Chen W, Lee JC, Cheng WE, Chen CH, Hsu WH, Shih CH: Pigtail catheters versus large-bore chest tubes for management of secondary spontaneous pneumothorax in adults. Am J Emerg Med 2006;24:795&ndash;780.
82.
Noppen M, Meysman M, D&rsquo;Haese J, Monsieur I, Verhaeghe W, Schlesser M, Vincken W: Comparison of video-assisted thoracoscopic talcage for recurrent primary versus persistent secondary spontaneous pneumothorax. Eur Respir J 1997;10:412&ndash;416.
83.
Alifano M, Roth T, Broet SC, Schussler O, Magdaleinat P, Regnard JF: Catamenial pneumothorax: a prospective study. Chest 2003;124:1004&ndash;1008.
84.
Augoulea A, Lambrinoudaki I, Christodoulakos G: Thoracic endometriosis syndrome. Respiration 2008;75:113&ndash;119.
85.
Bridges KC, Welch G, Silver M, Schinco MA, Esposito B: CT detection of occult pneumothorax in multiple trauma patients. J Emerg Med 1993;11:179&ndash;186.
86.
Johnson G: Traumatic pneumothorax: is a chest drain always necessary? J Accid Emerg Med 1996;13:173&ndash;174.
87.
Brown KT, Brody LA, Getrajdmann GI, Napp TE: Outpatient treatment of iatrogenic pneumothorax after needle biopsy. Radiology 1997;205:249&ndash;252.

Additional information

Previous articles in this series: 1. Froudarakis ME: Diagnostic work-up of pleural effusions. Respiration 2008;75:4–13. 2. Jantz MA, Antony VB: Pathophysiology of the pleura. Respiration 2008;75:121–133. 3. Koegelenberg CFN, Diacon AH, Bolliger CT: Parapneumonic pleural effusion and empyema. Respiration 2008;75:241–250. 4. Bouros D, Pneumatikos I, Tzouvelekis A: Pleural involvement in systemic autoimmune disorders. Respiration 2008;75:361–371. 5. Greillier L, Astoul P: Mesothelioma and asbestos-related pleural diseases. Respiration 2008;76:1–15.